Fast Five Quiz: Chronic Kidney Disease (CKD) Management

A. Brent Alper, Jr, MD, MPH

Disclosures

April 22, 2021

According to guidelines issued by the KDIGO workgroup, wider statin use among patients with CKD is recommended. Specific recommendations include:

  • Patients with an eGFR < 60 mL/min/1.73 m2 who are not being treated with long-term dialysis or kidney transplantation should be treated with a statin or a statin plus ezetimibe

  • Treatment with statins or statin/ezetimibe should not be initiated in adults with dialysis-dependent CKD

  • Patients already being treated with a statin at the time of dialysis should continue their statin

  • Statin treatment is recommended for adult kidney transplant patients because of an increased risk for coronary events

  • Adults aged 18-49 years with an eGFR < 60 mL/min/1.73 m2 who are not being treated with dialysis or kidney transplantation should be treated with statins if they have coronary disease, diabetes, prior ischemic stroke, or an estimated 10-year risk of coronary death or nonfatal myocardial infarction exceeding 10%

  • Adults ≥ 50 years of age with CKD and an eGFR ≥ 60 mL/min/1.73 m2 should be treated with a statin

In addition, lipid profile testing is recommended for all patients newly diagnosed with CKD. However, clinicians should note that low-density lipoprotein cholesterol alone is insufficient for assessing cardiovascular risk in individuals with CKD.

Learn more details about the management of CKD.

Editor's Recommendations

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....